Massachusetts General Hospital: Sarcoma trials

The registry lists 11 Sarcoma studies with Massachusetts General Hospital as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 4Phase 2 6Phase 4 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyEnrolling by invitationNCT03244020Phase 4
• A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable SarcomasCompletedNCT02448537Phase 2Results posted
• Olaparib in Adults With Recurrent/Metastatic Ewing's SarcomaCompletedNCT01583543Phase 2Results posted
• PCI-24781 in Combination With Doxorubicin to Treat SarcomaCompletedNCT01027910Phase 1/2Results posted
• Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue SarcomasCompletedNCT00592293Not applicableResults posted
• Bevacizumab and Radiation Therapy for SarcomasCompletedNCT00356031Phase 2Results posted
• Lurbinectedin + Doxorubicin In LeiomyosarcomaActive, not recruitingNCT05099666Phase 1/2
• Smartphone Confocal Microscopy for Diagnosing Kaposi's SarcomaCompletedNCT03050788Not applicable
• Ensuring Communication in Hospice by Oncology Study (ECHO)CompletedNCT02069769Not applicable
• Bevacizumab/Doxorubicin/Radiation for SarcomaActive, not recruitingNCT01746238Phase 1
• High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/SacrumCompletedNCT00592345Phase 1/2